Register Login

QUOIN PHARMACEUTICALS, LTD. (QNRX)

SymbolQNRX
NameQUOIN PHARMACEUTICALS, LTD.
SectorHEALTH CARE
RegionMiddle East
IndustryMedical/Dental Instruments
Address42127 PLEASANT FOREST COURT, ASHBURN, Virginia, 20148-7349, United States
Telephone+1 703 980-4182
Fax—
Email—
Websitehttps://www.quoinpharma.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001671502
Description

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Additional info from NASDAQ:
Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

2026-07-06 18:21

New Form PRE 14A - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001104659-26-080828 <b>Size:</b> 3 MB

Read more
2026-06-30 12:30

Quoin Pharmaceuticals Receives U.S. Notice of Allowance for Patent Covering Combination Treatment for Netherton Syndrome

Read more
2026-06-23 12:30

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

Read more
2026-06-18 12:30

Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003

Read more
2026-06-16 12:30

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Read more
2026-06-04 20:04

(70% Positive) QUOIN PHARMACEUTICALS, LTD. (QNRX) Announces Regulatory Update

Read more
2026-06-04 12:30

Quoin Pharmaceuticals Announces Japans MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Read more
2026-06-02 18:14

New Form SCHEDULE 13G - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001104659-26-069556 <b>Size:</b> 19 KB

Read more
2026-06-02 12:30

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

Read more
2026-06-02 07:09

New Form 424B3 - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001104659-26-069166 <b>Size:</b> 26 KB

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT07538583 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome Phase2 Netherton Syndrome Recruiting 2026-03-19 2027-03-31 ClinicalTrials.gov
NCT06953466 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome Phase2 Netherton Syndrome Recruiting 2025-07-01 2026-07-30 ClinicalTrials.gov
NCT05789056 Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Nethert… Phase2 Netherton Syndrome Recruiting 2023-03-14 2025-12-30 ClinicalTrials.gov
NCT05521438 Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton S… Phase2 Netherton Syndrome Active_Not_Recruiting 2022-06-23 2026-12-31 ClinicalTrials.gov
Total clinical trials: 4
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
QRX003, 4% Lotion Other Phase PHASE2 Netherton Syndrome RECRUITING NCT05789056
QRX003, 4% Lotion Other Phase PHASE2 Netherton Syndrome RECRUITING NCT06953466
QRX003-4% Lotion BID Other Phase PHASE2 Netherton Syndrome ACTIVE_NOT_RECRUITING NCT05521438
Vehicle Other Phase PHASE2 Netherton Syndrome ACTIVE_NOT_RECRUITING NCT05521438
QRX003-4% Lotion QAM Other Phase PHASE2 Netherton Syndrome ACTIVE_NOT_RECRUITING NCT05521438
QRX003-2% Lotion Other Phase PHASE2 Netherton Syndrome ACTIVE_NOT_RECRUITING NCT05521438
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
QRX003 Other Phase PHASE2 Netherton Syndrome RECRUITING NCT07538583
Total products: 15